Fred Hutchinson Cancer Research Center, founded in 1975 and located in Seattle, Washington, is a world-renowned nonprofit organization dedicated to cancer research and treatment. The center is operationally focused on pioneering innovative science that leads to advances in cancer treatment, prevention, and understanding the disease through its multifaceted research programs and clinical trials.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| FHUTCH 3.95% 2050-01-01 USDFred Hutchinson Cancer Research Center | United States | 2050-01-01 | 3.949 | 5.68 |
| FHUTCH 4.97% 2052-01-01 USDFred Hutchinson Cancer Research Center | United States | 2052-01-01 | 4.966 | 5.53 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Fred Hutch has issued bonds to support its research initiatives, including a notable $100 million bond issuance in 2015 aimed at funding new research facilities. The center's bonds typically offer competitive yields compared to the healthcare sector, reflecting strong demand for its critical research efforts. Recently, Fred Hutch announced plans to issue additional bonds to expand its immunotherapy programs, further solidifying its commitment to cutting-edge cancer treatments and research advancements.